Australia markets close in 2 hours 43 minutes

Leap Therapeutics, Inc. (5MC.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.6200-0.0600 (-2.24%)
At close: 09:24AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 98.68M
Enterprise value 33.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)160.75
Price/book (mrq)1.80
Enterprise value/revenue -62.52
Enterprise value/EBITDA 0.44

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-35.78%
S&P500 52-week change 326.27%
52-week high 38.5000
52-week low 31.0300
50-day moving average 32.5072
200-day moving average 32.1949

Share statistics

Avg vol (3-month) 365
Avg vol (10-day) 3N/A
Shares outstanding 538.26M
Implied shares outstanding 638.66M
Float 819.85M
% held by insiders 115.88%
% held by institutions 126.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.1:1
Last split date 321 June 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-75.03%
Return on equity (ttm)-136.82%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -85.92M
Net income avi to common (ttm)-81.41M
Diluted EPS (ttm)-3.6900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)70.64M
Total cash per share (mrq)2.76
Total debt (mrq)262k
Total debt/equity (mrq)0.44%
Current ratio (mrq)5.64
Book value per share (mrq)2.35

Cash flow statement

Operating cash flow (ttm)-43.75M
Levered free cash flow (ttm)-46.85M